Aprea Therapeutics, Inc. (APRE)

0.9381 +0.13 (+16.51%) USD  |  NASDAQ  |  Aug 25, 16:00
0.98 +0.04 (+4.47%) After-Hours: 19:19
More

Aprea Therapeutics Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for APRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
August 13, 2026 --
August 12, 2026 --
August 10, 2026 --
June 01, 2026 --
May 15, 2026 --
May 13, 2026 --
May 07, 2026 --
April 06, 2026 --
March 31, 2026 --
March 16, 2026 --
February 09, 2026 --
January 29, 2026 --
December 22, 2025 --
December 18, 2025 --
November 12, 2025 --
Date Value
August 12, 2025 --
July 15, 2025 --
May 14, 2025 --
April 04, 2025 --
March 25, 2025 --
January 15, 2025 --
November 08, 2024 --
November 07, 2024 --
August 12, 2024 --
May 14, 2024 --
March 26, 2024 --
November 10, 2023 --
August 10, 2023 --
March 10, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
Zymeworks, Inc. Upgrade
Rhythm Pharmaceuticals, Inc. Upgrade
Onconetix, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade